Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-17

FDA Approved: NIMODIPINE — Original Application (BIONPHARMA INC.)

View source ↗

Summary

FDA approves Bionpharma's nimodipine generic under an original ANDA, enabling market entry for this calcium channel blocker. Nimodipine is indicated to prevent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

ORIG AP for NIMODIPINE (NIMODIPINE)